Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2019 Financial Results

World News: . []

SAN DIEGO July 30 2019 GLOBE NEWSWIRE -- Fate Therapeutics Inc NASDAQ FATE a clinical-stage biopharmaceutical LINK  dedicated to the development of programmed cellular immunotherapies for LINK  and immune disorders LINK  today th at the ...

More news and information about Fate Therapeutics, Inc.

Published By:

Globe Newswire: 21:01 GMT Tuesday 30th July 2019

Published: .

Search for other references to "fate" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us